SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001562180-19-005302
Filing Date
2019-11-01
Accepted
2019-11-01 16:22:53
Documents
1
Period of Report
2019-02-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3/A  
1 PRIMARY DOCUMENT primarydocument.xml 3/A 3215
  Complete submission text file 0001562180-19-005302.txt   4583
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACHILLION PHARMACEUTICALS, INC 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Di Donato Brian (Reporting) CIK: 0001766498 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-33095 | Film No.: 191187089